Advanced Search

The story appears on

Page B3

April 29, 2024

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » District » Jiading

Biopharma business gets a boost with industry cluster

By Li Pin and Ye Fengting | 00:00 UTC+8 April 29, 2024 | Print Edition

Jiading is establishing a biopharmaceutical industry cluster worth more than 100 billion yuan (US$13.8 billion) with focus on high-performance medical equipment and precision medicine.

The district is working on significant initiatives such as United Imaging Town, Shanghai MedValley and Nanxiang Life Element Valley.

It intends to establish a strong industrial system in the biopharma sector, with a goal of 38.5 billion yuan in total output this year, or a 35 percent increase.

The United Imaging medical industrialization demonstration base, also known as United Imaging Town, is currently under construction. The second phase of the project is scheduled to be finished in 2025.

Covering some 9.5 square kilometers, it will grow into an international high-end medical equipment industrial cluster and a demonstration zone for industry-city integration.

United Imaging, the major player, will entice several upstream and downstream biopharmaceutical companies to locate in this industrial park. It has already attracted almost 200 businesses.

In a separate move, Ruijin Hospital’s innovation center and orthopedic traumatology institute were recently relocated to Shanghai MedValley in Malu.

“Jiading District and Ruijin Hospital are collaborating to build an innovation platform that combines healthcare and industry,” said Chang Qing, director of the innovation center.

“With this top-tier hospital’s high-quality scientific research and clinical resources, we can progress exceptional projects through clinical trials toward industrialization, ultimately benefiting the public.”

Since its inception in October, Shanghai MedValley has grown into a comprehensive industrial park that includes R&D and manufacturing.

Jiading has already attracted a total of 1,254 biopharmaceutical enterprises, including those involved in manufacturing, R&D, as well as services.

“In our ongoing efforts, Jiading will continue to strengthen its brand in the high-performance medical equipment and precision medicine industries,” said Jin Shizhen, deputy director of the district’s economic commission. “We will focus on expanding industrial capacity, modernizing industrial structure, and push for the development of thriving industrial clusters.”

Jiading


 

Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend